A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Did Meta help Lil Tay? Controversial influencer claims phony death post was put out by hackers
Thousands of crude 'penis fish' wash up on beach giving locals the willies
Stable Doodle AI turns your scribbles into sketches
IBM unveils new watsonx, AI and data platform
4 Numbers That Explain the Stock Market’s Miserable September
Score a new Mac mini for less than $700
Kai Cenat and IShowSpeed get Miami residence from Rumble's CEO to host livestreams, fans say 'Twitch fumbling so bad'
Believe it or not, Prime Day is a perfect time to snag an electric scooter on sale
